✦ LIBER ✦

Cisplatin, epirubicin, and lonidamine combination regimen as first-line chemotherapy for metastatic breast cancer: a pilot study

✍ Scribed by L. Dogliotti; S. Danese; A. Berruti; P. Zola; T. Buniva; A. Bottini; G. Richiardi; G. Moro; A. Farris; M. G. Baù; G. Porcile

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Epirubicin or epirubicin and cisplatin a

✍ Dorte Nielsen; Per Dombernowsky; Susanne Kornum Larsen; Ole Paaske Hansen; Torbe 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 115 KB

Multicenter phase II study of trastuzuma

✍ M. Venturini; C. Bighin; S. Monfardini; F. Cappuzzo; N. Olmeo; A. Durando; F. Pu 📂 Article 📅 2005 🏛 Springer US 🌐 English ⚖ 218 KB

A randomized phase III study comparing t

✍ G. Fountzilas; U. Dafni; M. A. Dimopoulos; A. Koutras; D. Skarlos; P. Papakostas 📂 Article 📅 2008 🏛 Springer US 🌐 English ⚖ 556 KB

Phase II study of vinorelbine (alternati

✍ Mario Campone; Maria Blasinska-Morawiec; Anna Tekiela; Piotr Koralewski; Jean-Ch 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 297 KB

Individually tailored treatment with epi

✍ T. Hatschek; L. Carlsson; Z. Einbeigi; E. Lidbrink; B. Linderholm; B. Lindh; N. 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 329 KB

Docetaxel plus epirubicin is a highly ac

✍ Serafín Morales; Antonio Lorenzo; Manuel Ramos; Pedro Ballesteros; Miguel Méndez 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 196 KB